January 16, 2026 a 05:00 pm
LH: Analysts Ratings - Labcorp Holdings Inc.
Labcorp Holdings Inc. continues to exhibit a robust analyst sentiment, largely characterized by a consistent influx of 'Buy' ratings over recent months. Despite a minor decline in the 'Strong Buy' category, the lack of 'Sell' or 'Strong Sell' recommendations highlights a stable and positive outlook from the analyst community. This sustained endorsement indicates potential confidence in the company's growth prospects and resilience in its business model.
Historical Stock Grades
The recent analyst ratings for Labcorp Holdings Inc. as of the latest data (2026-01-01) illustrate a positive outlook. The stock shows a stable trend with no 'Sell' or 'Strong Sell' ratings, emphasizing analysts' confidence in the company's performance.
| Rating Type | Count | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 12 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
The analyst sentiment for Labcorp Holdings Inc. has remained steady, with a persistent preference for 'Buy' ratings. Over the months, there is a slight reduction in 'Strong Buy' recommendations, counterbalanced by a stable 'Buy' count:
- Overall ratings have stabilized at around 20, with 'Buy' ratings consistently over 50% of total recommendations.
- The transition from 'Strong Buy' to 'Buy' indicates a shift towards cautious optimism.
Percentage Trends
A notable trend is the consistent percentage of 'Buy' ratings remaining strong, comprising approximately 60% of the total. This trend suggests a persistent positive sentiment despite market fluctuations:
- The 'Strong Buy' ratings have seen a decline from 20% to 10%, indicating a modest shift to more conservative positions.
- Increasing 'Hold' positions suggest growing caution, rising from 5% to 25% over the months.
Latest Analyst Recommendations
The latest recommendations for Labcorp Holdings Inc. have shown a sustained confidence from leading analyst firms, with no downgrades reported in recent months.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-07 | Overweight | Overweight | JP Morgan |
| 2025-10-29 | Buy | Buy | UBS |
| 2025-10-17 | Buy | Buy | UBS |
| 2025-10-17 | Outperform | Outperform | Mizuho |
| 2025-10-03 | Outperform | Outperform | Evercore ISI Group |
Analyst Recommendations with Change of Opinion
Analyst recommendations showing changes in opinion highlight occasional adjustments in sentiment, indicating dynamic market assessments based on new information.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-03-04 | Buy | Neutral | Citigroup |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
| 2024-10-30 | Buy | Hold | HSBC |
| 2024-03-25 | Buy | Hold | Argus Research |
| 2022-12-12 | Neutral | Buy | Citigroup |
Interpretation
The consistency in 'Buy' ratings underscores an enduring confidence in Labcorp Holdings Inc.'s market positioning. Minimal changes in analyst recommendations suggest a stable outlook, although the modest increase in 'Hold' ratings could imply growing caution due to market dynamics. The recent stability reflects a cautious optimism, highlighting confidence in the company's strategic positioning amidst varying economic conditions.
Conclusion
Labcorp Holdings Inc. demonstrates resilience with sustained positive analyst sentiment primarily driven by consistent 'Buy' recommendations. The slight decline in 'Strong Buy' ratings marks a cautious sentiment shift, yet the absence of 'Sell' ratings underscores robust fundamental confidence. As market conditions evolve, monitoring further shifts in recommendations will be crucial in understanding broader sentiment trends. Analysts see Labcorp Holdings Inc. as a stable, albeit cautiously approached investment, suggesting potential opportunities driven by intrinsic business strengths and market factors.